Palvella Therapeutics, Inc.
Clinical trials sponsored by Palvella Therapeutics, Inc., explained in plain language.
-
New gel could shrink painful skin vein bumps
Disease control OngoingThis study tests a gel called PTX-022 (sirolimus) for treating visible skin venous malformations. It involves 15 participants and aims to see if the gel is safe and improves the appearance of these malformations. The gel is applied directly to the skin, and doctors and patients w…
Phase: PHASE2 • Sponsor: Palvella Therapeutics, Inc. • Aim: Disease control
Last updated May 01, 2026 16:00 UTC
-
New gel could ease rare skin condition in phase 3 trial
Disease control OngoingThis study tests a gel called QTORIN 3.9% rapamycin on people aged 3 and older with microcystic lymphatic malformations, a rare skin condition causing fluid-filled bumps. The main goal is to see if the gel improves the condition after 24 weeks of daily use. About 51 participants …
Phase: PHASE3 • Sponsor: Palvella Therapeutics, Inc. • Aim: Disease control
Last updated Apr 30, 2026 15:49 UTC